今日视点：资本投资者需从“财务投资”走向“价值创造”

Core Viewpoint - The new regulation proposed by the China Securities Regulatory Commission aims to expand the types of strategic investors and promote the deep integration of "patient capital" with listed companies, shifting capital investors from "financial investment" to "value creation" [1][7]. Group 1: Expansion of Strategic Investors - The new regulation significantly broadens the definition of strategic investors to include various institutional investors such as national social security funds, basic pension insurance funds, corporate (occupational) annuities, commercial insurance funds, public funds, and bank wealth management [2][8]. - Capital investors are required to hold at least 5% of a listed company's shares and must introduce strategic resources or significantly improve the company's governance and internal controls [2][8]. Group 2: Role Transformation of Capital Investors - Institutional investors are encouraged to evolve from merely being secondary market traders or financial investors to becoming deep value discoverers and active shareholders [3][9]. - Public funds are urged to break free from short-term performance metrics and explore long-term locked products focused on improving corporate governance [3][9]. - Social security and insurance funds, which naturally possess long-term attributes, will have their advantages further enhanced, necessitating more proactive post-investment management [3][9]. Group 3: Macro Perspective on Capital Market Ecosystem - The rule revision is seen as a crucial step in restructuring the Chinese capital market ecosystem, enhancing the effectiveness of corporate governance and focusing on long-term sustainable development rather than short-term stock price fluctuations [4][10]. - A market supported by more "patient capital" will reflect the intrinsic value and long-term prospects of enterprises, improving the overall asset supply efficiency and investment attractiveness of the capital market [4][10]. - The relationship between listed companies and capital investors is expected to shift from transactional to partnership-oriented, with "patient capital" becoming a more frequent presence in the shareholder structure of quality listed companies [4][10]. Group 4: Future Implications for Capital Market - As capital market reforms progress, "patient capital" characterized by long-term holding and value creation is anticipated to become a key force influencing corporate governance [5][11]. - This transition requires capital investors to develop deep industry insights and governance capabilities, while listed companies must adopt a more open and collaborative mindset to effectively utilize these "capital + strategy" investors [5][11]. - Establishing pathways to convert "patient capital" into active strategic investors is essential for channeling financial resources into the real economy, ultimately fostering a more resilient and efficient high-quality development ecosystem in the Chinese capital market [5][11].